BioCentury
ARTICLE | Clinical News

Thin film ozone technology: Phase I and II Update

October 27, 1997 8:00 AM UTC

Medizone International Inc. (MZEI.U), Salt Lake City, Utah Product: Thin film ozone technology Indication: Treat HIV infection Status: MZEI.U plans to start Phase I/II testing in Italy in the first qu...